We are live on
!
Find out more
KB
Kimelman & Baird Portfolio holdings
AUM
$1.22B
1-Year Est. Return
11.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.9%
1 Year Est. Return
+11.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
-$86.4M
(-6.6%)
Cap. Flow
-$26.2M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
42.8%
Holding
275
New
12
Increased
27
Reduced
50
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$8.07M |
| 2 |
Cisco
CSCO
|
+$6.05M |
| 3 |
NVIDIA
NVDA
|
+$3M |
| 4 |
Travelers Companies
TRV
|
+$2.49M |
| 5 |
American Express
AXP
|
+$1.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Norfolk Southern
NSC
|
+$16.9M |
| 2 |
JPMorgan Chase
JPM
|
+$7.16M |
| 3 |
Mastercard
MA
|
+$4.01M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.2M |
| 5 |
SOLS
Solstice Advanced Materials
SOLS
|
+$1.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.74% |
| 2 | Financials | 18.47% |
| 3 | Technology | 18.41% |
| 4 | Consumer Discretionary | 15.76% |
| 5 | Healthcare | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Ball Corp
BALL
$17B
| $311K | 0.03% |
5,265
| – | – |
|
102
Evergy
EVRG
$20.1B
| $306K | 0.03% |
3,734
| – | – |
|
103
Colgate-Palmolive
CL
$72.6B
| $298K | 0.02% |
3,500
| – | – |
|
104
Texas Instruments
TXN
$255B
| $291K | 0.02% |
1,500
| – | – |
|
105
Newmont
NEM
$99.5B
| $231K | 0.02% |
2,130
+770
| +57% | +$88.8K |
|
106
Marathon Petroleum
MPC
$90.3B
| $230K | 0.02% |
942
| – | – |
|
107
Enbridge
ENB
$124B
| $228K | 0.02% |
4,220
| – | – |
|
108
Archer Daniels Midland
ADM
$41.4B
| $226K | 0.02% |
3,115
| – | – |
|
109
Fresenius Medical Care
FMS
$13.2B
| $220K | 0.02% |
9,734
| – | – |
|
110
EQT Corp
EQT
$33.2B
| $215K | 0.02% |
3,375
| – | – |
|
111
Walmart Inc
WMT
$871B
| $212K | 0.02% |
1,709
+424
| +33% | +$52.1K |
|
|
BNY
112
Bank of New York Mellon
BNY
$108B
| $202K | 0.02% |
1,700
| – | – |
|
113
Quaker Houghton
KWR
$2.63B
| $197K | 0.02% |
1,582
| – | – |
|
114
Berkshire Hathaway Class B
BRK.B
$1.07T
| $192K | 0.02% |
400
-100
| -20% | -$49.1K |
|
115
LCNB Corp
LCNB
$285M
| $179K | 0.01% |
11,500
| – | – |
|
116
Guardant Health
GH
$19.5B
| $176K | 0.01% |
1,900
| – | – |
|
117
Westlake Corp
WLK
$9.46B
| $175K | 0.01% |
1,500
| – | – |
|
118
Duke Energy
DUK
$102B
| $174K | 0.01% |
1,332
| – | – |
|
119
FMC
FMC
$1.42B
| $172K | 0.01% |
10,000
| – | – |
|
120
ServiceNow
NOW
$102B
| $172K | 0.01% |
1,645
+1,640
| +32,800% | +$193K |
|
121
Cummins
CMI
$91.7B
| $161K | 0.01% |
300
| – | – |
|
122
KeyCorp
KEY
$24.3B
| $160K | 0.01% |
8,000
| – | – |
|
123
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $152K | 0.01% |
2,250
| – | – |
|
124
Ashland
ASH
$3.04B
| $152K | 0.01% |
2,732
-1,450
| -35% | -$85.8K |
|
125
Kinder Morgan
KMI
$73.1B
| $151K | 0.01% |
4,500
| – | – |
|
Similar funds
DPI
NPIC
CS
AG
TIM
CCM
GC
LWIC
Kimelman & Baird's Q1 2026 Portfolio in Review
As of Q1 2026, Kimelman & Baird held 275 positions worth $1.22B, down 6.6% from $1.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Kimelman & Baird's Q1 2026 filing shows 12 new, 27 increased, 50 reduced and 12 closed positions. Its largest new stake was Travelers Companies: 8,514 shares worth $2.48M. The largest sale was Norfolk Southern, an estimated $16.9M.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 21% a quarter earlier, followed by Financials and Technology.
- Kimelman & Baird's largest Q1 2026 buy was Travelers Companies: 8,514 shares worth $2.48M.
- Kimelman & Baird added most to Regeneron Pharmaceuticals in Q1 2026, an estimated $8.07M increase.
- Kimelman & Baird's biggest Q1 2026 reduction was Norfolk Southern, cutting an estimated $16.9M.
- Kimelman & Baird fully exited Exact Sciences in Q1 2026, selling an estimated $203K.
- Kimelman & Baird's ten largest holdings make up 43% of its $1.22B portfolio in Q1 2026.
- Kimelman & Baird opened 12 new positions and closed 12 in Q1 2026.
- Kimelman & Baird's portfolio value fell 6.6% quarter-over-quarter to $1.22B.
Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.